Administrative Core
Administrative Core
批准号:
10688405
负责人:
Kimberly Stegmaier
金额:
$50.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-07 至 2024-06-30
关键词:
Administrative CoordinationAdministratorAnnual ReportsBasic ScienceBiologyChemistryChromatinCommunicationCommunitiesConflict (Psychology)Dana-Farber Cancer InstituteDecision MakingElementsEnsureEwings sarcomaFosteringFutureGrantIndividualInfrastructureInstitutionLaboratoriesLeadLeadershipLogisticsMonitorMovementOncoproteinsPediatric OncologyReportingResearchResearch PersonnelResearch Project GrantsResource AllocationResource SharingReview CommitteeScheduleSiteSpecialistStructureTechnologyTrainingUnited States National Institutes of HealthWorkcareer developmentdata exchangemeetingsmemberoperationoutreachoutreach programpediatric departmentpre-clinical researchprogramsresearch studyresponsesuccesstargeted treatmenttherapeutic target
中文摘要
项目摘要/摘要:行政核心A
管理核心A的目的是组织FusOnC2中心的组件
治疗靶向EWS-癌蛋白,并提供监督和领导的科学,
该中心的行政、财务方面。该中心联席主任金伯利·斯泰格迈尔博士和Dr。
Scott Armstrong将与一名专门的项目经理和管理员一起监督行政管理
协调本提案中概述的各种基础和临床前研究。核心A基础设施
将促进中心站点之间的关键沟通和数据交换,以实现协作研究,
从而促进研究结果的快速移动,以开发尤文的有针对性的治疗方法
肉瘤。核心A还将使我们的中心和FusOnC2之间的研究信息交换成为可能
整个财团。核心A的行政职能将包括组织会议、创建
外部科学审查委员会,对职业发展和外联方案的监督和跟踪
整个中心的科学进步。行政核心A的目标是:1)管理中心
物流和通信;2)促进中心内和其他中心内的合作研究
联盟;以及3)监测研究项目和核心,并为未来制定计划。
英文摘要
PROJECT SUMMARY/ABSTRACT: Administrative Core A
The purpose of the Administrative Core A is to organize the components of the FusOnC2 Center for
Therapeutic Targeting of EWS-oncoproteins and to provide oversight and leadership of the scientific,
administrative, and fiscal aspects of this Center. The Center Co-Directors, Dr. Kimberly Stegmaier and Dr.
Scott Armstrong, together with a dedicated Program Manager and Administrator, will oversee the administrative
coordination of the various basic and preclinical research studies outlined in this proposal. Core A infrastructure
will facilitate critical communication and exchange of data between Center sites to enable collaborative research,
thereby promoting rapid movement of findings towards developing targeted therapeutic approaches in Ewing
sarcoma. Core A will also enable the interchange of research information between our Center and the FusOnC2
Consortium at large. Administrative functions of Core A will include organization of meetings, creation of an
External Scientific Review Committee, oversight of career development and outreach programs and the tracking
of scientific progress across the Center. The objectives of Administrative Core A are: 1) to manage Center
logistics and communications; 2) to foster collaborative research within the Center and other Centers in the
Consortium; and 3) to monitor research Projects and Cores and plan for the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Pediatric Cancer Vulnerabilities
-
批准号:10737704
-
项目类别:
-
资助金额:$106.62万
-
财政年份:2023
-
负责人:Kimberly Stegmaier
-
依托单位:
Administrative Core
-
批准号:9600133
-
项目类别:
-
资助金额:$67.11万
-
财政年份:2018
-
负责人:Kimberly Stegmaier
-
依托单位:
Targeting SYK Kinase in AML
-
批准号:10220876
-
项目类别:
-
资助金额:$2.05万
-
财政年份:2017
-
负责人:Kimberly Stegmaier
-
依托单位:
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
-
批准号:10064577
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2017
-
负责人:Kimberly Stegmaier
-
依托单位:
Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer
-
批准号:10457896
-
项目类别:
-
资助金额:$102.55万
-
财政年份:2016
-
负责人:Kimberly Stegmaier
-
依托单位:
Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer
-
批准号:10225613
-
项目类别:
-
资助金额:$104.64万
-
财政年份:2016
-
负责人:Kimberly Stegmaier
-
依托单位:
Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer
-
批准号:9981667
-
项目类别:
-
资助金额:$109.2万
-
财政年份:2016
-
负责人:Kimberly Stegmaier
-
依托单位:
Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer
-
批准号:9328023
-
项目类别:
-
资助金额:$104.64万
-
财政年份:2016
-
负责人:Kimberly Stegmaier
-
依托单位:
Targeting BET-bromodomains in neuroblastoma
-
批准号:9066220
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2015
-
负责人:Kimberly Stegmaier
-
依托单位:
Validating Syk as a Target for AML Therapy
-
批准号:8296670
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2009
-
负责人:Kimberly Stegmaier
-
依托单位:
Validating Syk as a Target for AML Therapy
-
批准号:8081708
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2009
-
负责人:Kimberly Stegmaier
-
依托单位:
Validating Syk as a Target for AML Therapy
-
批准号:8463140
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2009
-
负责人:Kimberly Stegmaier
-
依托单位:
Validating Syk as a Target for AML Therapy
-
批准号:8759407
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2009
-
负责人:Kimberly Stegmaier
-
依托单位:
Validating Syk as a Target for AML Therapy
-
批准号:7695850
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2009
-
负责人:Kimberly Stegmaier
-
依托单位:
Chemical Genomics Approach to Leukemia Differentiation
-
批准号:6766928
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2003
-
负责人:Kimberly Stegmaier
-
依托单位:
Chemical Genomics Approach to Leukemia Differentiation
-
批准号:6895894
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2003
-
负责人:Kimberly Stegmaier
-
依托单位:
Chemical Genomics Approach to Leukemia Differentiation
-
批准号:6561688
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2003
-
负责人:Kimberly Stegmaier
-
依托单位:
Chemical Genomics Approach to Leukemia Differentiation
-
批准号:7251959
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2003
-
负责人:Kimberly Stegmaier
-
依托单位:
Chemical Genomics Approach to Leukemia Differentiation
-
批准号:7086938
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2003
-
负责人:Kimberly Stegmaier
-
依托单位:
海外基金